Off-shore companies (largely known for generic manufacturing) are leveraging their capacity, research talent, and lower costs to take on R&D for big pharma.

• 一些国外公司（我们大多听说这些公司是从事普通制造业）依靠其产能、研发天赋、低廉的成本获得了医药巨头们的研发订单。